Liu Tian, Lv Yi-Fei, Zhao Jing-Long, You Qi-Dong, Jiang Zheng-Yu
State Key Laboratory of Natural Medicines, And Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China.
State Key Laboratory of Natural Medicines, And Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
Free Radic Biol Med. 2021 May 20;168:129-141. doi: 10.1016/j.freeradbiomed.2021.03.034. Epub 2021 Mar 29.
The transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) participates in the activation of the antioxidant cytoprotective pathway and other important physiological processes to maintain cellular homeostasis. The dysregulation of NRF2 activity plays a role in various diseases, such as cardiovascular diseases, neurodegenerative diseases, and cancer. Thus, NRF2 activity is tightly regulated through multiple mechanisms, among which phosphorylation by kinases is critical in the posttranslational regulation of NRF2. For instance, PKC, casein kinase 2, and AMP-activated kinase positively, while GSK-3 negatively regulates NRF2 activity through phosphorylation of different sites. Here, we provide an overview of the phosphorylation regulation pattern of NRF2 and discuss the therapeutic potential of interventions targeting NRF2 phosphorylation.
转录因子核因子红细胞衍生 2 样 2(NRF2)参与抗氧化细胞保护途径及其他重要生理过程的激活,以维持细胞内稳态。NRF2 活性的失调在多种疾病中起作用,如心血管疾病、神经退行性疾病和癌症。因此,NRF2 活性通过多种机制受到严格调控,其中激酶磷酸化在 NRF2 的翻译后调控中至关重要。例如,蛋白激酶 C、酪蛋白激酶 2 和 AMP 激活的蛋白激酶通过对不同位点的磷酸化正向调控 NRF2 活性,而糖原合成酶激酶 3 则负向调控 NRF2 活性。在此,我们概述了 NRF2 的磷酸化调控模式,并讨论了针对 NRF2 磷酸化的干预措施的治疗潜力。